NCT06857747 2025-03-04
Disitamab Vedotin in Combination with Metronomic Chemotherapy in Advanced HER2-expressing Breast Cancer.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase NA Not yet recruiting
Clinical Trials
11 trialsNCT06156761 2023-12-05
Mitoxantrone Hydrochloride Liposome Combined With Capecitabine in Patients With HER-2 Negative Advanced Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase NA Unknown
NCT06015100 2023-08-29
Efficacy and Safety of Inetetamab Plus Pyrotiniband and Capecitabine in HER2-positive Metastatic Breast Cancer Patients With or Without Brain Metastasis
Xi'an International Medical Center Hospital
Phase NA Unknown
NCT03821454 2019-02-01
CALORIE
Zhejiang Cancer Hospital
Phase NA Unknown
NCT03647514 2018-12-10
Abraxane Combined With Xeloda as Neo-Adjuvant Chemotherapy in Early Breast Cancer
Zhejiang Cancer Hospital
Phase NA Unknown
NCT02028494 2018-09-07
CAP7/7
Latin American & Caribbean Society of Medical Oncology
Phase NA Unknown
NCT02597868 2016-03-29
A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep)
Zhejiang Cancer Hospital
Phase NA Unknown
NCT00146588 2015-03-24
Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer
Dana-Farber Cancer Institute
Phase NA Completed
NCT00953537 2015-02-10
Predicting Response to Capecitabine in Women With Metastatic Breast Cancer
Centre Antoine Lacassagne
Phase NA Completed
NCT00121134 2013-12-24
Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast Cancer
Dana-Farber Cancer Institute
Phase NA Completed
NCT00156312 2012-02-07
Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and Capecitabine
University of Michigan Rogel Cancer Center
Phase NA Completed